OBJECTIVE: The current study examined the impact of risperidone and divalproex on affective and working memory circuitry in patients with pediatric bipolar disorder (PBD). METHOD: This was a six-week, double-blind, randomized trial of risperidone plus placebo versus divalproex plus placebo for patients with mania (n = 21; 13.6 ± 2.5 years of age). Functional magnetic resonance imaging (fMRI) outcomes were measured using a block design, affective, N-back task with angry, happy, and neutral face stimuli at baseline and at 6-week follow-up. Matched healthy controls (HC; n = 15, 14.5 ± 2.8 years) were also scanned twice. RESULTS: In post hoc analyses on the significant interaction in a 3×2×2 analysis of variance (ANOVA) that included patient groups and HC, the risperidone group showed greater activation after treatment in response to the angry face condition in the left subgenual anterior cingulate cortex (ACC) and striatum relative to the divalproex group. The divalproex group showed greater activation relative to the risperidone group in the left inferior frontal gyrus and right middle temporal gyrus. Over the treatment course, the risperidone group showed greater change in activation in the left ventral striatum than the divalproex group, and the divalproex group showed greater activation change in left inferior frontal gyrus and right middle temporal gyrus than the risperidone group. Furthermore, each patient group showed increased activation relative to HC in fronto-striato-temporal regions over time. The happy face condition was potentially less emotionally challenging in this study and did not elicit notable findings. CONCLUSIONS: When patients performed a working memory task under emotional duress inherent in the paradigm, divalproex enhanced activation in a fronto-temporal circuit whereas risperidone increased activation in the dopamine (D₂) receptor-rich ventral striatum. Clinical trial registration information-Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar; http://www.clinicaltrials.gov; NCT00176202.
RCT Entities:
OBJECTIVE: The current study examined the impact of risperidone and divalproex on affective and working memory circuitry in patients with pediatric bipolar disorder (PBD). METHOD: This was a six-week, double-blind, randomized trial of risperidone plus placebo versus divalproex plus placebo for patients with mania (n = 21; 13.6 ± 2.5 years of age). Functional magnetic resonance imaging (fMRI) outcomes were measured using a block design, affective, N-back task with angry, happy, and neutral face stimuli at baseline and at 6-week follow-up. Matched healthy controls (HC; n = 15, 14.5 ± 2.8 years) were also scanned twice. RESULTS: In post hoc analyses on the significant interaction in a 3×2×2 analysis of variance (ANOVA) that included patient groups and HC, the risperidone group showed greater activation after treatment in response to the angry face condition in the left subgenual anterior cingulate cortex (ACC) and striatum relative to the divalproex group. The divalproex group showed greater activation relative to the risperidone group in the left inferior frontal gyrus and right middle temporal gyrus. Over the treatment course, the risperidone group showed greater change in activation in the left ventral striatum than the divalproex group, and the divalproex group showed greater activation change in left inferior frontal gyrus and right middle temporal gyrus than the risperidone group. Furthermore, each patient group showed increased activation relative to HC in fronto-striato-temporal regions over time. The happy face condition was potentially less emotionally challenging in this study and did not elicit notable findings. CONCLUSIONS: When patients performed a working memory task under emotional duress inherent in the paradigm, divalproex enhanced activation in a fronto-temporal circuit whereas risperidone increased activation in the dopamine (D₂) receptor-rich ventral striatum. Clinical trial registration information-Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar; http://www.clinicaltrials.gov; NCT00176202.
Authors: K Rubia; T Russell; S Overmeyer; M J Brammer; E T Bullmore; T Sharma; A Simmons; S C Williams; V Giampietro; C M Andrew; E Taylor Journal: Neuroimage Date: 2001-02 Impact factor: 6.556
Authors: Hilary P Blumberg; Joan Kaufman; Andres Martin; Dennis S Charney; John H Krystal; Bradley S Peterson Journal: Ann N Y Acad Sci Date: 2004-06 Impact factor: 5.691
Authors: Peter H Silverstone; Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock Journal: Hum Psychopharmacol Date: 2002-10 Impact factor: 1.672
Authors: B Geller; B Zimerman; M Williams; K Bolhofner; J L Craney; M P DelBello; C Soutullo Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-04 Impact factor: 8.829
Authors: Raquel E Gur; Claire McGrath; Robin M Chan; Lee Schroeder; Travis Turner; Bruce I Turetsky; Christian Kohler; David Alsop; Joseph Maldjian; J Daniel Ragland; Ruben C Gur Journal: Am J Psychiatry Date: 2002-12 Impact factor: 18.112
Authors: Hilary P Blumberg; Andrés Martin; Joan Kaufman; Hoi-Chung Leung; Pawel Skudlarski; Cheryl Lacadie; Robert K Fulbright; John C Gore; Dennis S Charney; John H Krystal; Bradley S Peterson Journal: Am J Psychiatry Date: 2003-07 Impact factor: 18.112
Authors: Karen Dineen Wagner; Elizabeth B Weller; Gabrielle A Carlson; Gary Sachs; Joseph Biederman; Jean A Frazier; Patricia Wozniak; Katherine Tracy; Ronald A Weller; Charles Bowden Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-10 Impact factor: 8.829
Authors: Isabelle E Bauer; Thomas W Frazier; Thomas D Meyer; Eric Youngstrom; Giovana B Zunta-Soares; Jair C Soares Journal: J Child Adolesc Psychopharmacol Date: 2015-10-15 Impact factor: 2.576
Authors: Manpreet K Singh; Kiki D Chang; Michael C Chen; Ryan G Kelley; Amy Garrett; Myles M Mitsunaga; Layla Bararpour; Meghan Howe; Allan L Reiss; Ian H Gotlib Journal: Bipolar Disord Date: 2012-09 Impact factor: 6.744
Authors: Ezra Wegbreit; Alexandra B Weissman; Grace K Cushman; Megan E Puzia; Kerri L Kim; Ellen Leibenluft; Daniel P Dickstein Journal: Bipolar Disord Date: 2015-05-08 Impact factor: 6.744
Authors: M A Brotman; W-L Tseng; A K Olsavsky; S J Fromm; E J Muhrer; J G Rutenberg; C M Deveney; N E Adleman; C A Zarate; D S Pine; E Leibenluft Journal: Psychol Med Date: 2013-08-12 Impact factor: 7.723